ConductScience.org, home

Paper1962075

Experimental leishmaniasis in humans: review.

Melby PC. Rev Infect Dis, 1991. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Experimental leishmaniasis in humans: review. Papers, record 1962075. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1962075

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experimental leishmaniasis in humans: review.
PubMed
Journal
Rev Infect Dis
PubMed
Year
1991
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2019-08-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Melby PCP C

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Insect VectorsMajor topic
LeishmaniaMajor topic
LeishmaniasisMajor topic
PsychodidaeMajor topic
Animals
Humans

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
39095597Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis.Nat Med2024https://conductscience.org/library/papers/39095597PubMed
37805813Climate change and cutaneous leishmaniasis in the province of Ghardaïa in Algeria: A model-based approach to predict disease outbreaks.Ann Saudi Med2023https://conductscience.org/library/papers/37805813PubMed
36365010Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs.Pathogens2022https://conductscience.org/library/papers/36365010PubMed
34693027A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study).Wellcome Open Res2021https://conductscience.org/library/papers/34693027PubMed
34664543Vaccines against leishmaniasis: using controlled human infection models to accelerate development.Expert Rev Vaccines2021https://conductscience.org/library/papers/34664543PubMed
34547025Human leishmaniasis vaccines: Use cases, target population and potential global demand.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/34547025PubMed
29922288Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania.Front Immunol2018https://conductscience.org/library/papers/29922288PubMed
26371247Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum.J Immunol2015https://conductscience.org/library/papers/26371247PubMed
25473946Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection.PLoS Pathog2014https://conductscience.org/library/papers/25473946PubMed
23339200Restricted outbreak of American tegumentary leishmaniasis with high microfocal transmission.Am J Trop Med Hyg2013https://conductscience.org/library/papers/23339200PubMed
22292030Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters.PLoS One2012https://conductscience.org/library/papers/22292030PubMed
20207869Urban transmission of American cutaneous leishmaniasis in Argentina: spatial analysis study.Am J Trop Med Hyg2010https://conductscience.org/library/papers/20207869PubMed
18372625Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.J Parasitol2008https://conductscience.org/library/papers/18372625PubMed
16517909First report of Leishmania infantum in French Guiana: canine visceral leishmaniasis imported from the Old World.J Clin Microbiol2006https://conductscience.org/library/papers/16517909PubMed
15730396Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.Clin Exp Immunol2005https://conductscience.org/library/papers/15730396PubMed
14573692Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.Infect Immun2003https://conductscience.org/library/papers/14573692PubMed
9782133Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.J Exp Med1998https://conductscience.org/library/papers/9782133PubMed
9367403Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.Clin Exp Immunol1997https://conductscience.org/library/papers/9367403PubMed
8627163Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.J Exp Med1996https://conductscience.org/library/papers/8627163PubMed
7729921A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.Infect Immun1995https://conductscience.org/library/papers/7729921PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1962075

GET https://conductscience.org/api/papers/v1/1962075/cited_by?page=2